Q1 2023 Holdings
Filed 2023-05-15 | 74 holdings | $303.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $4.3M | 40,000 | 1.4% |
| Inozyme Pharma Inc | COM | 45790W108 | $4.3M | 751,796 | 1.4% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $4.4M | 357,287 | 1.4% |
| Morphic Hldg Inc | COM | 61775R105 | $5.1M | 135,863 | 1.7% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $5.3M | 320,000 | 1.8% |
| Moderna Inc(MRNA)Call | COM | 60770K107 | $5.4M | 35,000 | 1.8% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $6.2M | 202,834 | 2.1% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $6.3M | 881,329 | 2.1% |
| Bridgebio Pharma Inc(BBIO)Put | COM | 10806X102 | $6.5M | 389,800 | 2.1% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $7.0M | 529,369 | 2.3% |
| Bridgebio Pharma Inc | NOTE 2.250% 2/0 | 10806XAD4 | $7.1M | $11,000,000 | 2.4% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $7.4M | $10,000,000 | 2.4% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $7.7M | 113,224 | 2.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $7.8M | 221,463 | 2.6% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $8.7M | 260,008 | 2.9% |
| Verona Pharma PLC(VRNA) | SPONSORED ADR | 925050106 | $9.1M | 452,821 | 3.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $9.3M | 380,000 | 3.1% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $9.4M | 1,083,118 | 3.1% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $10.4M | 622,249 | 3.4% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $12.8M | 120,000 | 4.2% |
| Prometheus Biosciences Inc | COM | 74349U108 | $16.1M | 150,000 | 5.3% |
| Spdr S&P 500 ETF Trtr Unit(SPY)Call | TR UNIT | 78462F103 | $18.4M | 45,000 | 6.1% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $22.5M | 93,000 | 7.4% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $22.6M | 976,021 | 7.5% |